484 lines
No EOL
126 KiB
HTML
484 lines
No EOL
126 KiB
HTML
<?xml version="1.0" encoding="utf-8"?>
|
||
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
|
||
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
|
||
|
||
<head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
|
||
<!-- AppResources meta begin -->
|
||
<meta name="paf-app-resources" content="" />
|
||
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
||
|
||
<!-- AppResources meta end -->
|
||
|
||
<!-- TemplateResources meta begin -->
|
||
<meta name="paf_template" content="" />
|
||
|
||
<!-- TemplateResources meta end -->
|
||
|
||
<!-- Logger begin -->
|
||
<meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK50696" /><meta name="ncbi_domain" content="mlprobe" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK50696/" /><meta name="ncbi_pagename" content="Selective HePTP Inhibitors: Probe 1 - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
|
||
<!-- Logger end -->
|
||
|
||
<title>Selective HePTP Inhibitors: Probe 1 - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf</title>
|
||
|
||
<!-- AppResources external_resources begin -->
|
||
<link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>
|
||
|
||
<!-- AppResources external_resources end -->
|
||
|
||
<!-- Page meta begin -->
|
||
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="Probe Reports from the NIH Molecular Libraries Program [Internet]" /><meta name="citation_title" content="Selective HePTP Inhibitors: Probe 1" /><meta name="citation_publisher" content="National Center for Biotechnology Information (US)" /><meta name="citation_date" content="2010/10/04" /><meta name="citation_author" content="Eduard Sergienko" /><meta name="citation_author" content="Ekatarina Bobkova" /><meta name="citation_author" content="Stefan Vasile" /><meta name="citation_author" content="Hongbin Yuan" /><meta name="citation_author" content="Ying Su" /><meta name="citation_author" content="Russell Dahl" /><meta name="citation_author" content="Li Yang" /><meta name="citation_author" content="Thomas DY Chung" /><meta name="citation_author" content="Shakeela Dad" /><meta name="citation_author" content="Tomas Mustelin" /><meta name="citation_author" content="Wallace Liu" /><meta name="citation_author" content="David A Critton" /><meta name="citation_author" content="Rebecca Page" /><meta name="citation_author" content="Lutz Tautz" /><meta name="citation_pmid" content="21433388" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK50696/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Selective HePTP Inhibitors: Probe 1" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Center for Biotechnology Information (US)" /><meta name="DC.Contributor" content="Eduard Sergienko" /><meta name="DC.Contributor" content="Ekatarina Bobkova" /><meta name="DC.Contributor" content="Stefan Vasile" /><meta name="DC.Contributor" content="Hongbin Yuan" /><meta name="DC.Contributor" content="Ying Su" /><meta name="DC.Contributor" content="Russell Dahl" /><meta name="DC.Contributor" content="Li Yang" /><meta name="DC.Contributor" content="Thomas DY Chung" /><meta name="DC.Contributor" content="Shakeela Dad" /><meta name="DC.Contributor" content="Tomas Mustelin" /><meta name="DC.Contributor" content="Wallace Liu" /><meta name="DC.Contributor" content="David A Critton" /><meta name="DC.Contributor" content="Rebecca Page" /><meta name="DC.Contributor" content="Lutz Tautz" /><meta name="DC.Date" content="2010/10/04" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK50696/" /><meta name="description" content="Tyrosine phosphorylation plays a key role in signal transduction and the regulation of a broad set of physiological processes characteristic of multicellular organisms. Hematopoietic protein tyrosine phosphate (HePTP) is a tyrosine phosphatase expressed in hematopoietic cells with specificity for the dephosphorylation of Erk and p38 MAP kinases (MAPKs). It has been found that HePTP is often dysregulated in the preleukemic disorder myelodysplastic syndrome, as well as in acute myelogeneous leukemia. The identified probe ML119 (CID-1357397) selectively inhibits HePTP activity. Since this probe scaffold was discovered through its activity in the HePTP assays with small molecule substrates, it is proposed that this inhibition occurs through direct targeting of the HePTP active site. The probe inhibits through fast equilibrium as judged by the lack of apparent effect when pre-incubated with phosphatase proteins. Thus, small molecule inhibitors of HePTP would be useful as molecular probes for studying the mechanism of signal transduction and MAP kinase regulation. In addition, these probes may have therapeutic potential for the treatment of hematopoietic malignancies, such as acute myeloid leukemia, where HePTP has been reported to be overexpressed." /><meta name="og:title" content="Selective HePTP Inhibitors: Probe 1" /><meta name="og:type" content="book" /><meta name="og:description" content="Tyrosine phosphorylation plays a key role in signal transduction and the regulation of a broad set of physiological processes characteristic of multicellular organisms. Hematopoietic protein tyrosine phosphate (HePTP) is a tyrosine phosphatase expressed in hematopoietic cells with specificity for the dephosphorylation of Erk and p38 MAP kinases (MAPKs). It has been found that HePTP is often dysregulated in the preleukemic disorder myelodysplastic syndrome, as well as in acute myelogeneous leukemia. The identified probe ML119 (CID-1357397) selectively inhibits HePTP activity. Since this probe scaffold was discovered through its activity in the HePTP assays with small molecule substrates, it is proposed that this inhibition occurs through direct targeting of the HePTP active site. The probe inhibits through fast equilibrium as judged by the lack of apparent effect when pre-incubated with phosphatase proteins. Thus, small molecule inhibitors of HePTP would be useful as molecular probes for studying the mechanism of signal transduction and MAP kinase regulation. In addition, these probes may have therapeutic potential for the treatment of hematopoietic malignancies, such as acute myeloid leukemia, where HePTP has been reported to be overexpressed." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK50696/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-mlprobe-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/mlprobe/ml119/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK50696/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} .body-content h2, .body-content .h2 {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list .graphic {display:inline-block !important} .temp-labeled-list img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/books.min.js"> </script><meta name="book-collection" content="NONE" />
|
||
|
||
<!-- Page meta end -->
|
||
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8CAA947D668531000000000031002B.m_13" />
|
||
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4216701/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/4207974/4206132/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3411343/3882866.css" media="print" /></head>
|
||
<body class="book-part">
|
||
<div class="grid">
|
||
<div class="col twelve_col nomargin shadow">
|
||
<!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
|
||
<div class="sysmessages">
|
||
<noscript>
|
||
<p class="nojs">
|
||
<strong>Warning:</strong>
|
||
The NCBI web site requires JavaScript to function.
|
||
<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
|
||
</p>
|
||
</noscript>
|
||
</div>
|
||
<!--/.sysmessage-->
|
||
<div class="wrap">
|
||
<div class="page">
|
||
<div class="top">
|
||
<div id="universal_header">
|
||
<section class="usa-banner">
|
||
<div class="usa-accordion">
|
||
<header class="usa-banner-header">
|
||
<div class="usa-grid usa-banner-inner">
|
||
<img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
|
||
<p>An official website of the United States government</p>
|
||
<button class="non-usa-accordion-button usa-banner-button" aria-expanded="false" aria-controls="gov-banner-top" type="button">
|
||
<span class="usa-banner-button-text">Here's how you know</span>
|
||
</button>
|
||
</div>
|
||
</header>
|
||
<div class="usa-banner-content usa-grid usa-accordion-content" id="gov-banner-top" aria-hidden="true">
|
||
<div class="usa-banner-guidance-gov usa-width-one-half">
|
||
<img class="usa-banner-icon usa-media_block-img" src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg" alt="Dot gov" />
|
||
<div class="usa-media_block-body">
|
||
<p>
|
||
<strong>The .gov means it's official.</strong>
|
||
<br />
|
||
Federal government websites often end in .gov or .mil. Before
|
||
sharing sensitive information, make sure you're on a federal
|
||
government site.
|
||
</p>
|
||
</div>
|
||
</div>
|
||
<div class="usa-banner-guidance-ssl usa-width-one-half">
|
||
<img class="usa-banner-icon usa-media_block-img" src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg" alt="Https" />
|
||
<div class="usa-media_block-body">
|
||
<p>
|
||
<strong>The site is secure.</strong>
|
||
<br />
|
||
The <strong>https://</strong> ensures that you are connecting to the
|
||
official website and that any information you provide is encrypted
|
||
and transmitted securely.
|
||
</p>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</section>
|
||
<div class="usa-overlay"></div>
|
||
<header class="ncbi-header" role="banner" data-section="Header">
|
||
|
||
<div class="usa-grid">
|
||
<div class="usa-width-one-whole">
|
||
|
||
<div class="ncbi-header__logo">
|
||
<a href="/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
|
||
<img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
|
||
</a>
|
||
</div>
|
||
|
||
<div class="ncbi-header__account">
|
||
<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
|
||
<button id="account_info" class="header-button" style="display:none" aria-controls="account_popup" type="button">
|
||
<span class="fa fa-user" aria-hidden="true">
|
||
<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" width="20px" height="20px">
|
||
<g style="fill: #fff">
|
||
<ellipse cx="12" cy="8" rx="5" ry="6"></ellipse>
|
||
<path d="M21.8,19.1c-0.9-1.8-2.6-3.3-4.8-4.2c-0.6-0.2-1.3-0.2-1.8,0.1c-1,0.6-2,0.9-3.2,0.9s-2.2-0.3-3.2-0.9 C8.3,14.8,7.6,14.7,7,15c-2.2,0.9-3.9,2.4-4.8,4.2C1.5,20.5,2.6,22,4.1,22h15.8C21.4,22,22.5,20.5,21.8,19.1z"></path>
|
||
</g>
|
||
</svg>
|
||
</span>
|
||
<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
|
||
<span class="sr-only">Show account info</span>
|
||
</button>
|
||
</div>
|
||
|
||
<div class="ncbi-popup-anchor">
|
||
<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
|
||
<div class="ncbi-popup-head">
|
||
<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu" type="button">
|
||
<span class="fa fa-times">
|
||
<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" width="24px" height="24px">
|
||
<path d="M38 12.83l-2.83-2.83-11.17 11.17-11.17-11.17-2.83 2.83 11.17 11.17-11.17 11.17 2.83 2.83 11.17-11.17 11.17 11.17 2.83-2.83-11.17-11.17z"></path>
|
||
</svg>
|
||
</span>
|
||
<span class="usa-sr-only">Close</span></button>
|
||
<h4>Account</h4>
|
||
</div>
|
||
<div class="account-user-info">
|
||
Logged in as:<br />
|
||
<b><span class="username" id="uname_long">username</span></b>
|
||
</div>
|
||
<div class="account-links">
|
||
<ul class="usa-unstyled-list">
|
||
<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
|
||
<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
|
||
<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
|
||
<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
|
||
</ul>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
</div>
|
||
</div>
|
||
</header>
|
||
<div role="navigation" aria-label="access keys">
|
||
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
|
||
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
|
||
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
|
||
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
|
||
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
|
||
</div>
|
||
<section data-section="Alerts">
|
||
<div class="ncbi-alerts-placeholder"></div>
|
||
</section>
|
||
</div>
|
||
<div class="header">
|
||
<div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
|
||
<div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" data-ac_dict="bookshelf-search">Books</option><option value="pubmed">PubMed</option><option value="clinvar">ClinVar</option><option value="refseq" class="last">RefSeq</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="protfam">Protein Family Models</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
|
||
<a href="/books/browse/">Browse Titles</a>
|
||
</li><li>
|
||
<a href="/books/advanced/">Advanced</a>
|
||
</li><li class="help">
|
||
<a href="/books/NBK3833/">Help</a>
|
||
</li><li class="disclaimer">
|
||
<a target="_blank" data-ga-category="literature_resources" data-ga-action="link_click" data-ga-label="disclaimer_link" href="https://www.ncbi.nlm.nih.gov/books/about/disclaimer/">Disclaimer</a>
|
||
</li></ul></div>
|
||
</div>
|
||
|
||
|
||
|
||
<!--<component id="Page" label="headcontent"/>-->
|
||
|
||
</div>
|
||
<div class="content">
|
||
<!-- site messages -->
|
||
<!-- Custom content 1 -->
|
||
<div class="col1">
|
||
|
||
</div>
|
||
|
||
<div class="container">
|
||
<div id="maincontent" class="content eight_col col">
|
||
<!-- Custom content in the left column above book nav -->
|
||
<div class="col2">
|
||
|
||
</div>
|
||
|
||
<!-- Book content -->
|
||
|
||
|
||
<!-- Custom content between navigation and content -->
|
||
<div class="col3">
|
||
|
||
</div>
|
||
|
||
<div class="document">
|
||
<div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="Table of Contents Page" href="/books/n/mlprobe/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-mlprobe-lrg.png" alt="Cover of Probe Reports from the NIH Molecular Libraries Program" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>Probe Reports from the NIH Molecular Libraries Program [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK50696_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK50696_dtls__"><div>Bethesda (MD): National Center for Biotechnology Information (US); 2010-.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/mlprobe/">Contents</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/mlprobe/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search this book" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search this book" submit="false" style="padding: 0.1em 0.4em;" /></div></form></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/mlprobe/ml120/" title="Previous page in this title">< Prev</a><a class="active page_link next" href="/books/n/mlprobe/ml118/" title="Next page in this title">Next ></a></div></div></div></div></div>
|
||
<div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK50696_"><span class="title" itemprop="name">Selective HePTP Inhibitors: Probe 1</span></h1><p class="contrib-group"><span itemprop="author">Eduard Sergienko</span>, <span itemprop="author">Ekatarina Bobkova</span>, <span itemprop="author">Stefan Vasile</span>, <span itemprop="author">Hongbin Yuan</span>, <span itemprop="author">Ying Su</span>, <span itemprop="author">Russell Dahl</span>, <span itemprop="author">Li Yang</span>, <span itemprop="author">Thomas DY Chung</span>, <span itemprop="author">Shakeela Dad</span>, <span itemprop="author">Tomas Mustelin</span>, <span itemprop="author">Wallace Liu</span>, <span itemprop="author">David A Critton</span>, <span itemprop="author">Rebecca Page</span>, and <span itemprop="author">Lutz Tautz</span>.</p><p class="small">Received: <span itemprop="datePublished">November 1, 2009</span>; Last Update: <span itemprop="dateModified">October 4, 2010</span>.</p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="_abs_rndgid_" itemprop="description"><p>Tyrosine phosphorylation plays a key role in signal transduction and the regulation of a broad set of physiological processes characteristic of multicellular organisms. Hematopoietic protein tyrosine phosphate (HePTP) is a tyrosine phosphatase expressed in hematopoietic cells with specificity for the dephosphorylation of Erk and p38 MAP kinases (MAPKs). It has been found that HePTP is often dysregulated in the preleukemic disorder myelodysplastic syndrome, as well as in acute myelogeneous leukemia. The identified probe ML119 (CID-1357397) selectively inhibits HePTP activity. Since this probe scaffold was discovered through its activity in the HePTP assays with small molecule substrates, it is proposed that this inhibition occurs through direct targeting of the HePTP active site. The probe inhibits through fast equilibrium as judged by the lack of apparent effect when pre-incubated with phosphatase proteins. Thus, small molecule inhibitors of HePTP would be useful as molecular probes for studying the mechanism of signal transduction and MAP kinase regulation. In addition, these probes may have therapeutic potential for the treatment of hematopoietic malignancies, such as acute myeloid leukemia, where HePTP has been reported to be overexpressed.</p></div><div class="h2"></div><p><b>Assigned Assay Grant #:</b> 1 X01 MH077603-01</p><p><b>Screening Center Name & PI:</b> Burnham Center for Chemical Genomics & Dr John C Reed</p><p><b>Chemistry Center Name & PI:</b> Burnham Center for Chemical Genomics & Dr John C Reed</p><p><b>Assay Submitter & Institution:</b> Dr Tomas Mustelin w/Dr Lutz Tautz & Burnham Institute for Medical Research</p><p><b>PubChem Summary Bioassay Identifier (AID):</b>
|
||
<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/2085" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID-2085</a></p><div id="ml119.s2"><h2 id="_ml119_s2_">Probe Structure & Characteristics</h2><p>Scaffold 2: Imidazothiazolidinones</p><div id="ml119.fu1" class="figure"><div class="graphic"><img src="/books/NBK50696/bin/ml119fu1.jpg" alt="Image ml119fu1" /></div></div><div id="ml119.tu1" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK50696/table/ml119.tu1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml119.tu1_lrgtbl__"><table><thead><tr><th id="hd_h_ml119.tu1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">CID</th><th id="hd_h_ml119.tu1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Target Name</th><th id="hd_h_ml119.tu1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">IC50/EC50 (nM) [SID, AID]</th><th id="hd_h_ml119.tu1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Anti-target Name(s)</th><th id="hd_h_ml119.tu1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">IC50/EC50 (μM) [SID, AID]</th><th id="hd_h_ml119.tu1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Selectivity</th><th id="hd_h_ml119.tu1_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Secondary Assay(s) Name: IC50/EC50 (nM) [SID, AID]</th></tr></thead><tbody><tr><td headers="hd_h_ml119.tu1_1_1_1_1" rowspan="2" colspan="1" style="text-align:center;vertical-align:top;">CID 1357397<br /><br /><b><a href="/pcsubstance/?term=ML119[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML119</a></b></td><td headers="hd_h_ml119.tu1_1_1_1_2" rowspan="2" colspan="1" style="text-align:center;vertical-align:top;">HePTP</td><td headers="hd_h_ml119.tu1_1_1_1_3" rowspan="2" colspan="1" style="text-align:center;vertical-align:top;">IC50 235 nM<br /><a href="https://pubchem.ncbi.nlm.nih.gov/substance/26514203" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID-26514203</a><br /><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1077" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID-1077</a></td><td headers="hd_h_ml119.tu1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">VHR1</td><td headers="hd_h_ml119.tu1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1.3 μM<br /><a href="https://pubchem.ncbi.nlm.nih.gov/substance/26514203" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID-26514203</a><br /><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1957" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID-1957</a></td><td headers="hd_h_ml119.tu1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">5X</td><td headers="hd_h_ml119.tu1_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;"></td></tr><tr><td headers="hd_h_ml119.tu1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">MKP-3</td><td headers="hd_h_ml119.tu1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">4.9 μM<br /><a href="https://pubchem.ncbi.nlm.nih.gov/substance/26514203" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID-26514203</a><br /><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1055" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID-1055</a></td><td headers="hd_h_ml119.tu1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">21X</td><td headers="hd_h_ml119.tu1_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;"></td></tr></tbody></table></div></div></div><div id="ml119.s3"><h2 id="_ml119_s3_">Recommendations for the scientific use of this probe</h2><p>Protein tyrosine phosphatases (PTPs), working with protein tyrosine kinases (PTKs), control the phosphorylation state of many proteins in the signal transduction pathways. HePTP is a tyrosine phosphatase expressed in hematopoietic cells and regulates the MAP kinases Erk and p38. It has been found that HePTP is often dysregualted in the preleukemic disorder myelodysplastic syndrome, as well as in acute myelogeneous leukemia. Small molecule inhibitors of HePTP will be useful as molecular probes for studying the mechanism of signal transduction and MAP kinase regulation, and may have therapeutic potential for the treatment of hematopoietic malignancies for example in acute myeloid leukemia where HePTP has been reported to be overexpressed.</p></div><div id="ml119.s4"><h2 id="_ml119_s4_">1. Scientific Rationale for Project</h2><div id="ml119.s5"><h3>Specific aims</h3><p>The goal of this project was to identify small molecule compounds that were potent and specific inhibitors of HePTP.</p></div><div id="ml119.s6"><h3>Background and Significance</h3><p>Tyrosine phosphorylation [<a class="bk_pop" href="#ml119.r1">1</a>] is a key mechanism for signal transduction and the regulation of a broad set of physiological processes characteristic of multicellular organisms, such as integration of signal transduction pathways, decisions to proliferate, differentiate, or die, activation of large gene transcription programs, cell motility and morphology, and the transport of molecules in or out of cells. Tyrosine phosphorylation is also instrumental in the coordination of these processes among neighboring cells, for example within the immune system [<a class="bk_pop" href="#ml119.r2" data-bk-pop-others="ml119.r3 ml119.r4 ml119.r5">2–5</a>]. The importance of tyrosine phosphorylation in normal cell physiology is also well illustrated by the many inherited or acquired human diseases that stem from abnormalities in the protein tyrosine phosphatases (PTPs)[<a class="bk_pop" href="#ml119.r6" data-bk-pop-others="ml119.r7 ml119.r8">6–8</a>] and protein tyrosine kinases (PTKs) that catalyze the reversible tyrosine phosphorylation of proteins. Severe phenotypes are also observed in many PTP or PTK knock-out mice, and in many cases the immune system is affected.</p><div id="ml119.s7"><h4>Rationale</h4><div id="ml119.s8"><h5>The hematopoietic phosphatase HePTP</h5><p>HePTP [<a class="bk_pop" href="#ml119.r9">9</a>,<a class="bk_pop" href="#ml119.r10">10</a>] is a 38-kDa enzyme, which consists mainly of a PTP domain with only a short (~50 residues) N-terminal extension (<a class="figpopup" href="/books/NBK50696/figure/ml119.f1/?report=objectonly" target="object" rid-figpopup="figml119f1" rid-ob="figobml119f1">Fig. 1</a>). HePTP is expressed in bone marrow, thymus, spleen, lymph nodes, and all myeloid and lymphoid lineages and cell lines [<a class="bk_pop" href="#ml119.r9" data-bk-pop-others="ml119.r10 ml119.r11">9–11</a>]. Studies from our laboratory have shown that transient expression of HePTP in T cells caused a clear reduction in TCR-induced transcriptional activation of a reporter gene driven by an NFAT/AP-1 element taken from the IL-2 gene promoter [<a class="bk_pop" href="#ml119.r12">12</a>]. In contrast, a catalytically inactive C270S mutant of HePTP had no effect, suggesting that the PTP activity of HePTP was required for inhibition. HePTP also reduced the TCR-induced activation of the MAP kinases Erk1, Erk2, and p38α, but not of the N-terminal c-Jun kinase (Jnk). HePTP also did not affect the activity or phosphorylation of Mek, the upstream activator of Erk, and all examined tyrosine phosphorylation events upstream of Mek appeared intact. Furthermore, we found that HePTP bound specifically to Erk1, Erk2 and p38α in intact T cells and dephosphorylated the critical PTyr in their activation loop [<a class="bk_pop" href="#ml119.r13">13</a>]. This reaction caused rapid inactivation of the bound Erk or p38. We mapped the region of HePTP responsible for the specific binding of Erk and p38 to amino acids 10 – 30 in the non-catalytic N-terminus of HePTP [<a class="bk_pop" href="#ml119.r13">13</a>]. Moreover, it was reported [<a class="bk_pop" href="#ml119.r14">14</a>,<a class="bk_pop" href="#ml119.r15">15</a>] that the two related PTPs, STEP and PCPTP, also bind Erk and p38 through a short motif termed the kinase interacting motif (KIM), which is well conserved also in HePTP within residues 15 – 30. Thus, the binding and regulation of MAP kinases is common property of this subgroup of PTPs.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figml119f1" co-legend-rid="figlgndml119f1"><a href="/books/NBK50696/figure/ml119.f1/?report=objectonly" target="object" title="Figure 1" class="img_link icnblk_img figpopup" rid-figpopup="figml119f1" rid-ob="figobml119f1"><img class="small-thumb" src="/books/NBK50696/bin/ml119f1.gif" src-large="/books/NBK50696/bin/ml119f1.jpg" alt="Figure 1. Crystal structure and aa sequence of HePTP." /></a><div class="icnblk_cntnt" id="figlgndml119f1"><h4 id="ml119.f1"><a href="/books/NBK50696/figure/ml119.f1/?report=objectonly" target="object" rid-ob="figobml119f1">Figure 1</a></h4><p class="float-caption no_bottom_margin">Crystal structure and aa sequence of HePTP. In the sequence, the KIM is in blue, the
|
||
PTP domain in green with the PTP signature motif underlined, and the phosphorylation sites in red. In the structure, colors indicate α-helices, β-sheets <a href="/books/NBK50696/figure/ml119.f1/?report=objectonly" target="object" rid-ob="figobml119f1">(more...)</a></p></div></div><p>It is now well established that HePTP associates through its KIM with the inactive unphosphorylated forms of Erk and p38 in resting leukocytes, at least in T cells and in K652 erythroleukemia cells [<a class="bk_pop" href="#ml119.r13">13</a>,<a class="bk_pop" href="#ml119.r16" data-bk-pop-others="ml119.r17 ml119.r18 ml119.r19 ml119.r20">16–20</a>]. This complex can be disrupted by phosphorylation at S23 in the KIM by cAMP-dependent kinase [<a class="bk_pop" href="#ml119.r16">16</a>] or perhaps by phosphorylation at T45 and S72 by the bound MAP kinases [<a class="bk_pop" href="#ml119.r13">13</a>]. Interestingly, TCR signaling also induces some S23 phosphorylation and dissociation of Erk and p38 from the inhibitory HePTP [<a class="bk_pop" href="#ml119.r19">19</a>]. HePTP remains in the cytosol and apparently cannot reach activated Erk and p38 in the nucleus, which therefore are allowed to remain active. Some 30 – 60 min later, the transcription of the genes for several MKPs is induced and these proteins begin to accumulate in the nucleus, where they dephosphorylate both phosphoamino acids in the activation loop of Erk. This results in complete inactivation of Erk, which shuttles back to the cytosol and reassociates with HePTP. This is referred to as the “sequential phosphatase model” [<a class="bk_pop" href="#ml119.r21">21</a>] and it is as an example of how different PTPs are used in a spatially and temporally ordered manner to control the extent, location, and duration of MAP kinase activation. However, reality is clearly even more complex in live cells, which also express many other MAP kinase phosphatases.</p></div><div id="ml119.s9"><h5>HePTP in hematopoietic malignancies</h5><p>The HePTP gene is located on chromosome 1q32 [<a class="bk_pop" href="#ml119.r22">22</a>], which is often found in extra copies (usually partial trisomy) in bone marrow cells from patients with myelodysplastic syndrome [<a class="bk_pop" href="#ml119.r23">23</a>,<a class="bk_pop" href="#ml119.r24">24</a>], which is characterized by disturbed hematopoiesis and an increased risk of acute leukemia. Amplification and overexpression of HePTP was reported in a case of acute myelogenous leukemia [<a class="bk_pop" href="#ml119.r22">22</a>]. Conversely, deletions of 1q32 have been reported in non-Hodgkin lymphomas and chronic lymphoproliferative disorders [<a class="bk_pop" href="#ml119.r25">25</a>]. These findings suggest that excess HePTP may correlate with reduced proliferation (in myelodysplastic syndrome) and loss of HePTP with increased cell proliferation and/or survival. The finding that the HePTP gene is transcriptionally activated in T cells treated with IL-2 [<a class="bk_pop" href="#ml119.r9">9</a>,<a class="bk_pop" href="#ml119.r26">26</a>] supports a connection with proliferation. Although mRNA levels also increased several fold upon stimulation of normal mouse lymphocytes with phytohemagglutinin, lipopolysaccharide, Concanavalin A or anti-CD3 [<a class="bk_pop" href="#ml119.r26">26</a>], the HePTP protein was present in resting cells and its amount increased only moderately.</p></div></div></div></div><div id="ml119.s10"><h2 id="_ml119_s10_">2. Project Description</h2><div id="ml119.s11"><h3>a. Original goal for probe characteristics</h3><p>No CPDP was written (or required) for this MLSCN phase of the project (cycle 2). However, the ideal probe would have a potency of 1 µM or better. The main goal was to identify compounds that inhibit HePTP and are selective against other phosphatases.</p></div><div id="ml119.s12"><h3>b. Information for each Assay Implemented and Screening Run</h3><div id="ml119.s13"><h4>i. PubChem Bioassay Name(s), AID(s), Assay-Type (Primary, DR, Counterscreen, Secondary)</h4><div id="ml119.t1" class="table"><h3><span class="label">Table 1</span><span class="title">PubChem Assay Summaries for Probe project</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK50696/table/ml119.t1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml119.t1_lrgtbl__"><table class="no_top_margin"><thead><tr><th id="hd_h_ml119.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">PubChem BioAssay Name</th><th id="hd_h_ml119.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">AIDs</th><th id="hd_h_ml119.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Probe Type</th><th id="hd_h_ml119.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Assay Type</th><th id="hd_h_ml119.t1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Assay Format</th><th id="hd_h_ml119.t1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Assay Detection & well format</th></tr></thead><tbody><tr><td headers="hd_h_ml119.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Chemical Inhibitors of HePTP, a Leukemia Target [Summary]</td><td headers="hd_h_ml119.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/2085" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">2085</a></td><td headers="hd_h_ml119.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">N/A</td><td headers="hd_h_ml119.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">N/A</td><td headers="hd_h_ml119.t1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">N/A</td><td headers="hd_h_ml119.t1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">N/A</td></tr><tr><td headers="hd_h_ml119.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Target [Confirmatory]</td><td headers="hd_h_ml119.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/521" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">521</a></td><td headers="hd_h_ml119.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Inhibitor</td><td headers="hd_h_ml119.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Primary</td><td headers="hd_h_ml119.t1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Biochemical</td><td headers="hd_h_ml119.t1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Colorimetric (384)</td></tr><tr><td headers="hd_h_ml119.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">In Vitro HePTP Dose Response Colorimetric Assay for SAR Study [Confirmatory]</td><td headers="hd_h_ml119.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1059" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">1059</a></td><td headers="hd_h_ml119.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Inhibitor</td><td headers="hd_h_ml119.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Dry-powder SAR</td><td headers="hd_h_ml119.t1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Biochemical</td><td headers="hd_h_ml119.t1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Colorimetric (384)</td></tr><tr><td headers="hd_h_ml119.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Fluorescent secondary assay for dose-response confirmation of chemical inhibitors of HePTP [Confirmatory]</td><td headers="hd_h_ml119.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1077" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">1077</a></td><td headers="hd_h_ml119.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Inhibitor</td><td headers="hd_h_ml119.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Secondary</td><td headers="hd_h_ml119.t1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Biochemical</td><td headers="hd_h_ml119.t1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Fluorescence (384)</td></tr><tr><td headers="hd_h_ml119.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">SAR VHR1 Fluorescent Assay for In Vitro dose response studies [Confirmatory]</td><td headers="hd_h_ml119.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1957" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">1957</a></td><td headers="hd_h_ml119.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Inhibitor</td><td headers="hd_h_ml119.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Secondary</td><td headers="hd_h_ml119.t1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Biochemical</td><td headers="hd_h_ml119.t1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Fluorescence (384)</td></tr><tr><td headers="hd_h_ml119.t1_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">In Vitro MKP-3 Dose Response Assay for SAR Study [Confirmatory]</td><td headers="hd_h_ml119.t1_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/1055" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">1055</a></td><td headers="hd_h_ml119.t1_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Inhibitor</td><td headers="hd_h_ml119.t1_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">In vitro SAR</td><td headers="hd_h_ml119.t1_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Biochemical</td><td headers="hd_h_ml119.t1_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Fluorescence (384)</td></tr></tbody></table></div></div></div><div id="ml119.s14"><h4>ii. Assay Rationale & Description</h4><p>The primary HTS and dose-response confirmation assays (<a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/521" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">AID-521</a>) were based on utilization of a small molecule substrate of HePTP, p-nitrophenol phosphate (pNPP), which is dephosphorylated by the enzyme and a number of other phosphatases to generate p-nitrophenol and phosphate. Each of the products could be detected independently. In our reaction, the phosphate product was measured with Biomol Green™ reagent. The resulting phosphomolybdylate complex with this malachite green-based indicator yields a deep green color. Any compound that inhibits the p-NPP-based reaction is expected to inhibit any other catalytic event of catalyzed HePTP.</p><p>In this assay 112,438 compounds (comprising the MLSCN library at the time of screening and DIVERset of Chembridge available at Burnham HTS core facility) were tested. The average Z′ for this assay was 0.8, the signal to background ratio was 6.4, the signal to noise ratio was 300 and the signal window was 12.3.</p><div id="ml119.s15"><h5>Assay materials</h5><div id="ml119.t2" class="table"><h3><span class="label">Table 2</span><span class="title">Reagents used for the uHTS experiments</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK50696/table/ml119.t2/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml119.t2_lrgtbl__"><table class="no_top_margin"><thead><tr><th id="hd_h_ml119.t2_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">Reagents</th><th id="hd_h_ml119.t2_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:bottom;">Vendor</th></tr></thead><tbody><tr><td headers="hd_h_ml119.t2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HePTP protein</td><td headers="hd_h_ml119.t2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Provided by Dr. Mustelin’s & Dr. Tautz’s lab (Burnham Institute for Medical Research)</td></tr><tr><td headers="hd_h_ml119.t2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">pNPP pellets</td><td headers="hd_h_ml119.t2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Sigma-Aldrich (S0942)</td></tr><tr><td headers="hd_h_ml119.t2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Biomol Green</td><td headers="hd_h_ml119.t2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">BIOMOL Research Laboratories, Inc (AK-111)</td></tr></tbody></table></div></div><p>
|
||
<b>HePTP assay materials</b></p><ol><li class="half_rhythm"><div>HePTP protein was provided by Dr. Mustelin (Burnham Institute for Medical Research, La Jolla, CA). The pNPP pellets were obtained from Sigma-Aldrich (S0942). Biomol Green reagent was purchased from BIOMOL Research Laboratories, Inc (AK-111)</div></li><li class="half_rhythm"><div>Assay Buffer: 50 mM Bis-Tris, pH 6.0, 2.5 mM DTT, 0.0125% Tween 20.</div></li><li class="half_rhythm"><div>HePTP working solution contained 6.875 nM HePTP in assay buffer. Solution was prepared fresh prior to use.</div></li><li class="half_rhythm"><div>pNPP working solution contained 1 mM pNPP in MQ water. Solution was prepared fresh prior to use.</div></li><li class="half_rhythm"><div>Vanadate working solution - 45 mM Na3VO4 in 10% DMSO</div></li></ol><p><b>HePTP HTS protocol</b></p><ol><li class="half_rhythm"><div>4 uL of 100 µM compounds in 10% DMSO were dispensed in columns 3–24 of Greiner 384-well clear microtiter plates (781101).</div></li><li class="half_rhythm"><div>4 uL of the following solutions were using the Multidrop bulk dispenser (Thermo):</div><ol class="lower-alpha"><li class="half_rhythm"><div>10% DMSO column 1 (negative control)</div></li><li class="half_rhythm"><div>45 mM Na3VO4 in 10% DMSO - column 2 (positive control).</div></li></ol></li><li class="half_rhythm"><div>8 uL of HePTP working solution was added to the whole plate using WellMate bulk dispenser (Matrix).</div></li><li class="half_rhythm"><div>8 uL of pNPP working solution was added to the whole plate using WellMate bulk dispenser (Matrix).</div></li><li class="half_rhythm"><div>Final concentrations of the components in the assay were as follows:</div><ol class="lower-alpha"><li class="half_rhythm"><div>20 mM Bis-Tris, pH 6.0, 1.0 mM DTT, 0.005% Tween 20.</div></li><li class="half_rhythm"><div>2.75 nM HePTP (columns 1–24)</div></li><li class="half_rhythm"><div>0.4 mM pNPP (columns 1–24)</div></li><li class="half_rhythm"><div>9 mM Na3VO4 (column 2)</div></li><li class="half_rhythm"><div>2 % DMSO (columns 1–24)</div></li><li class="half_rhythm"><div>20 µM compounds (columns 3–24)</div></li></ol></li><li class="half_rhythm"><div>Plates were incubated for 1h at room temperature.</div></li><li class="half_rhythm"><div>40 uL of Biomol Green reagent was added to the entire plate using the WellMate bulk dispenser (Matrix).</div></li><li class="half_rhythm"><div>Plates were incubated for 30 mins at room temperature</div></li><li class="half_rhythm"><div>Absorbance at 620 nm was measured on the Envision plate reader (PerkinElmer).</div></li><li class="half_rhythm"><div>Data analysis was performed using CBIS software (ChemInnovations, Inc).</div></li></ol></div><div id="ml119.s18"><h5>Rationale for confirmatory, counter and selectivity assays</h5><p>The confirmatory assay for HePTP is based on O-methyl fluorescein phosphate substrate (Sigma-Aldrich, cat # M2629) that is hydrolyzed into highly fluorescent O-methyl fluorescein and phosphate products. This assay was preferred to the colorimetric assay since the progress curves of the reaction could be easily acquired and utilized for weeding out time-dependent inhibitors.</p><p>HePTP is a protein tyrosine phosphatase with specificity for dephosphorylation of Erk and p38 MAP kinases (MAPKs). Thus for future utility of the chemical probes, it is important to establish their selectivity against other phosphatases involved in regulation of MAPKs, particularly the ones with overlapping substrate specificity. We utilized two dual-specificity phosphatases, MKP-3 and VHR1 dephosphorylating Erk and Erk/Jnk kinases, respectively, to establish the selectivity of the probes. The assays for MKP-3 and VHR were based on the O-methyl fluorescein phosphate substrate, similar to an alternative assay developed for HePTP.</p><p>Both MKP-3 and VHR are targets of specific MLSCN/MLPCN projects assigned to our center. We opportunistically utilized them for counter screening the hits of the HePTP inhibitor discovery project.</p></div></div><div id="ml119.s19"><h4>iii. Summary of Results</h4><p>The current probe originated from the historical HePTP project supported by the MLSCN grant X01 MH077603-01. Compound CID2861757 (MLS-0046352, <a href="https://pubchem.ncbi.nlm.nih.gov/substance/7977434" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">SID-7977434</a>,) was identified as a primary hit of the HePTP screen. Dry powder compound, CID1357397 (MLS-009081), was purchased from a commercial source for confirmation. After performing the counter screen of this HePTP hit in MKP-3 and later VHR assays, we realized that this molecule was very selective towards HePTP. The compound was active in a cell-based assay assessing the phosphorylation state of Erk MAPK in Jurkat cells. Commercial compounds were purchased for the SAR study. From the purchased compounds we were able to nominate CID1357397 (MLS-0090801) as a probe (see SAR <a href="#ml119.s13">section 2bi</a> below). This selective HePTP inhibitor could provide an invaluable tool to study HePTP pharmacology and potentially lead to a discovery and development of HePTP-specific therapeutic agents.</p><div id="ml119.fu2" class="figure"><div class="graphic"><img src="/books/NBK50696/bin/ml119fu2.jpg" alt="Image ml119fu2" /></div></div></div></div><div id="ml119.s20"><h3>c. Probe Optimization</h3><div id="ml119.s21"><h4>i. Description of SAR & chemistry strategy (including structure and data) that led to the probe</h4><p>SAR was developed by the analog-by-catalog approach for this scaffold. Compounds were purchased to explore R1 and R2 (<a class="figpopup" href="/books/NBK50696/figure/ml119.f2/?report=objectonly" target="object" rid-figpopup="figml119f2" rid-ob="figobml119f2">Figure 1</a>). Ortho –COOH as R1 is preferred. Replacing the ortho –COOH at R1 with –NO2 (CID5341934,(MLS-0091942)) or –Cl (CID2300608 (MLS-0091956)) reduces the inhibition by more than 20 folds (<a class="figpopup" href="/books/NBK50696/table/ml119.t3/?report=objectonly" target="object" rid-figpopup="figml119t3" rid-ob="figobml119t3">Table 3</a>). For R2, Bromide as a substituent contributes more to the inhibition than methyl substituent (CID5341943, (MLS-0091943)) and H (CID2243732 (MLS-0091939)).</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figml119f2" co-legend-rid="figlgndml119f2"><a href="/books/NBK50696/figure/ml119.f2/?report=objectonly" target="object" title="Figure 1" class="img_link icnblk_img figpopup" rid-figpopup="figml119f2" rid-ob="figobml119f2"><img class="small-thumb" src="/books/NBK50696/bin/ml119f2.gif" src-large="/books/NBK50696/bin/ml119f2.jpg" alt="Figure 1. Probe analogs R1 & R2 variations." /></a><div class="icnblk_cntnt" id="figlgndml119f2"><h4 id="ml119.f2"><a href="/books/NBK50696/figure/ml119.f2/?report=objectonly" target="object" rid-ob="figobml119f2">Figure 1</a></h4><p class="float-caption no_bottom_margin">Probe analogs R1 & R2 variations. </p></div></div><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figml119t3"><a href="/books/NBK50696/table/ml119.t3/?report=objectonly" target="object" title="Table 3" class="img_link icnblk_img figpopup" rid-figpopup="figml119t3" rid-ob="figobml119t3"><img class="small-thumb" src="/books/NBK50696/table/ml119.t3/?report=thumb" src-large="/books/NBK50696/table/ml119.t3/?report=previmg" alt="Table 3. SAR studies on probe CID1357397 [ML119]." /></a><div class="icnblk_cntnt"><h4 id="ml119.t3"><a href="/books/NBK50696/table/ml119.t3/?report=objectonly" target="object" rid-ob="figobml119t3">Table 3</a></h4><p class="float-caption no_bottom_margin">SAR studies on probe CID1357397 [<i>ML119</i>]. </p></div></div></div></div></div><div id="ml119.s22"><h2 id="_ml119_s22_">3. Probe</h2><div id="ml119.s23"><h3>a. Chemical name of probe compound</h3><p>2-{5-[(7-bromo-3-oxopyridino[3′,2′-4,5]imidazo[2,1-b]1,3-thiazolidin-2-ylidene)methyl]-2-furyl}benzoic acid [<b><a href="/pcsubstance/?term=ML119[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML119</a></b>]</p></div><div id="ml119.s24"><h3>b. Probe chemical structure including stereochemistry</h3><div id="ml119.fu3" class="figure"><div class="graphic"><img src="/books/NBK50696/bin/ml119fu9.jpg" alt="Image ml119fu9" /></div></div></div><div id="ml119.s25"><h3>c. Structural verification information of probe SID</h3><p>Probe SID number is 26514203</p><p>Purity: >95% (HPLC-MS)</p><div id="ml119.fu4" class="figure"><div class="graphic"><img src="/books/NBK50696/bin/ml119fu10.jpg" alt="Image ml119fu10" /></div></div><p><b>ES-MS m/z 470 [M+H]</b></p><div id="ml119.fu5" class="figure"><div class="graphic"><img src="/books/NBK50696/bin/ml119fu11.jpg" alt="Image ml119fu11" /></div></div></div><div id="ml119.s26"><h3>d. PubChem CID (corresponding to the SID)</h3><p>PubChem CID is CID1357397</p></div><div id="ml119.s27"><h3>e. Availability from a vendor</h3><p>This probe is commercially available from vendor, Labotest, cat. No. LT00237558.</p></div><div id="ml119.s28"><h3>f. MLS#'s of probe molecule and five related samples that were submitted to the SMR collection</h3><div id="ml119.t4" class="table"><h3><span class="label">Table 4</span><span class="title">Submission of Probe and 5 analogs to the MLSMR</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK50696/table/ml119.t4/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml119.t4_lrgtbl__"><table class="no_top_margin"><thead><tr><th id="hd_h_ml119.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Probe/analog</th><th id="hd_h_ml119.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS#(DPI)</th><th id="hd_h_ml119.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-# (BCCG#)</th><th id="hd_h_ml119.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">SID</th><th id="hd_h_ml119.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">CID</th><th id="hd_h_ml119.t4_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Source (vendor or BCCG syn)</th><th id="hd_h_ml119.t4_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Amt (mg)</th><th id="hd_h_ml119.t4_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Date submitted</th></tr></thead><tbody><tr><td headers="hd_h_ml119.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Probe<br /><b><a href="/pcsubstance/?term=ML119[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML119</a></b></td><td headers="hd_h_ml119.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS002554729</td><td headers="hd_h_ml119.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">0090801</td><td headers="hd_h_ml119.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/26514203" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">26514203</a></td><td headers="hd_h_ml119.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">1357397</td><td headers="hd_h_ml119.t4_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Labotest</td><td headers="hd_h_ml119.t4_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">50</td><td headers="hd_h_ml119.t4_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">11/02/2009</td></tr><tr><td headers="hd_h_ml119.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Analog1</td><td headers="hd_h_ml119.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS002554732</td><td headers="hd_h_ml119.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">0091943</td><td headers="hd_h_ml119.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/26513897" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">26513897</a></td><td headers="hd_h_ml119.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">5341943</td><td headers="hd_h_ml119.t4_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemBridge</td><td headers="hd_h_ml119.t4_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">20</td><td headers="hd_h_ml119.t4_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">11/02/2009</td></tr><tr><td headers="hd_h_ml119.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Analog2</td><td headers="hd_h_ml119.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS002554730</td><td headers="hd_h_ml119.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">0091939</td><td headers="hd_h_ml119.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/26513883" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">26513883</a></td><td headers="hd_h_ml119.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2243732</td><td headers="hd_h_ml119.t4_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemBridge</td><td headers="hd_h_ml119.t4_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">20</td><td headers="hd_h_ml119.t4_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">11/02/2009</td></tr><tr><td headers="hd_h_ml119.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Analog3</td><td headers="hd_h_ml119.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS002554731</td><td headers="hd_h_ml119.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">0091942</td><td headers="hd_h_ml119.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/26513896" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">26513896</a></td><td headers="hd_h_ml119.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">5341934</td><td headers="hd_h_ml119.t4_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemBridge</td><td headers="hd_h_ml119.t4_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">20</td><td headers="hd_h_ml119.t4_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">11/02/2009</td></tr><tr><td headers="hd_h_ml119.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Analog4</td><td headers="hd_h_ml119.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS002554734</td><td headers="hd_h_ml119.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">0091956</td><td headers="hd_h_ml119.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/26513917" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">26513917</a></td><td headers="hd_h_ml119.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2300608</td><td headers="hd_h_ml119.t4_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemBridge</td><td headers="hd_h_ml119.t4_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">20</td><td headers="hd_h_ml119.t4_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">11/02/2009</td></tr><tr><td headers="hd_h_ml119.t4_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">Analog5</td><td headers="hd_h_ml119.t4_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS002554733</td><td headers="hd_h_ml119.t4_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">0091944</td><td headers="hd_h_ml119.t4_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/26513898" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">26513898</a></td><td headers="hd_h_ml119.t4_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">2258411</td><td headers="hd_h_ml119.t4_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">ChemBridge</td><td headers="hd_h_ml119.t4_1_1_1_7" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">20</td><td headers="hd_h_ml119.t4_1_1_1_8" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">11/02/2009</td></tr></tbody></table></div></div></div><div id="ml119.s29"><h3>g. Mode of action for biological activity of probe</h3><p>The reported probe compound CID1357397 (MLS-0090801) selectively inhibits HePTP activity. Since the probe scaffold was discovered through its activity in the HePTP assays with small molecule substrates, it is most likely that it inhibits via a direct targeting of the HePTP active site.. The probe compound inhibits through fast equilibrium as judged by no apparent effect of their pre-incubation with phosphatase proteins. No time-dependent inhibition is observed as demonstrated by the linear progress curves of the HePTP phosphatase reaction in the presence of various concentrations of the probe compound CID1357397 (MLS-0090801).</p><div id="ml119.f3" class="figure bk_fig"><div class="graphic"><img src="/books/NBK50696/bin/ml119f3.jpg" alt="Figure 2. The progress curves are strictly linear, showing slowing down with incubation time." /></div><h3><span class="label">Figure 2</span><span class="title">The progress curves are strictly linear, showing slowing down with incubation
|
||
time</span></h3><div class="caption"><p>This is consistent with the absence of time-dependent inhibition of HePTP phosphatase reaction in the presence of the probe compound CID1357397 (MLS-0090801)</p></div></div><div id="ml119.s30"><h4>Cell-based activity and specificity evaluation of HePTP inhibitors</h4><p>For the development of HePTP lead structures, membrane permeability and inhibition of HePTP activity inside intact cells was crucial for compound classes to being further considered. In T cells, HePTP is known to dephosphorylate the activation loops of the Erk and p38 kinases to terminate signaling via the T cell receptor (TCR). Therefore, <i>bona fide</i> HePTP inhibitors should affect TCR-induced activation levels of Erk and p38. To probe these phosphorylation sites with specific antibodies, we incubated Jurkat T cells with selected compounds at 40 µM concentration or vehicle (DMSO) at 37°C for 45 min (<a class="figpopup" href="/books/NBK50696/figure/ml119.f4/?report=objectonly" target="object" rid-figpopup="figml119f4" rid-ob="figobml119f4">Figure 3</a>). Cells were then TCR-stimulated (with OKT3) for 5 min, and reactions were stopped by adding lysis buffer. Immunoblotting was done with pErk and pp38 phospho-specific antibodies. An anti-phospho-MEK blot was included as a specificity control within the Ras-Raf-MEK-MAPK signaling cascade. MEK directly activates Erk and p38. Therefore, by verifying unchanged MEK activation, augmented pErk and pp38 levels should not be the result of a more active kinase upstream of Erk and p38. Antibodies towards Erk, p38, and MEK were used on stripped membranes in order to verify equal loading between lanes. Results (<a class="figpopup" href="/books/NBK50696/figure/ml119.f4/?report=objectonly" target="object" rid-figpopup="figml119f4" rid-ob="figobml119f4">Figure 3</a>) show that probe CID1357397 (MLS-0090801) and analogs CID5341934 (MLS-0091942), CID2258411 (MLS-0091944) and CID2300608 (MLS-0091956) augment both pErk and pp38 levels, while pMEK was not affected. In addition, the probe compound CID1357397, which had the lowest IC50 value (0.24 µM) in the <i>in vitro</i> assay with recombinant HePTP, was also subjected to a dose-response immunoblot experiment using the same assay format (<a class="figpopup" href="/books/NBK50696/figure/ml119.f5/?report=objectonly" target="object" rid-figpopup="figml119f5" rid-ob="figobml119f5">Figure 4</a>). Taking the slight differences in loading between the DMSO control and the 4 µM assay point into account, the effect of CID1357397 (MLS-0090801) on Erk and p38 activation peaks between 1 and 4 µM, indicating that a concentration that is 10 fold higher than the <i>in vitro</i> IC50 value yields the highest effect in cells.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figml119f4" co-legend-rid="figlgndml119f4"><a href="/books/NBK50696/figure/ml119.f4/?report=objectonly" target="object" title="Figure 3" class="img_link icnblk_img figpopup" rid-figpopup="figml119f4" rid-ob="figobml119f4"><img class="small-thumb" src="/books/NBK50696/bin/ml119f4.gif" src-large="/books/NBK50696/bin/ml119f4.jpg" alt="Figure 3. Immunoblot analysis of HePTP inhibitors in Jurkat T cells." /></a><div class="icnblk_cntnt" id="figlgndml119f4"><h4 id="ml119.f4"><a href="/books/NBK50696/figure/ml119.f4/?report=objectonly" target="object" rid-ob="figobml119f4">Figure 3</a></h4><p class="float-caption no_bottom_margin">Immunoblot analysis of HePTP inhibitors in Jurkat T cells. Cells were incubated with
|
||
vehicle (DMSO, 0.2%) or inhibitors at 40 µM concentration for 45 min at 37°C prior to T cell receptor stimulation with OKT3 for 5 min. Cell lysates were <a href="/books/NBK50696/figure/ml119.f4/?report=objectonly" target="object" rid-ob="figobml119f4">(more...)</a></p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figml119f5" co-legend-rid="figlgndml119f5"><a href="/books/NBK50696/figure/ml119.f5/?report=objectonly" target="object" title="Figure 4" class="img_link icnblk_img figpopup" rid-figpopup="figml119f5" rid-ob="figobml119f5"><img class="small-thumb" src="/books/NBK50696/bin/ml119f5.gif" src-large="/books/NBK50696/bin/ml119f5.jpg" alt="Figure 4. Dose-response immunoblot analysis of HePTP Probe compound CID1357397 (MLS-0090801) in Jurkat T cells." /></a><div class="icnblk_cntnt" id="figlgndml119f5"><h4 id="ml119.f5"><a href="/books/NBK50696/figure/ml119.f5/?report=objectonly" target="object" rid-ob="figobml119f5">Figure 4</a></h4><p class="float-caption no_bottom_margin">Dose-response immunoblot analysis of HePTP Probe compound CID1357397 (MLS-0090801) in Jurkat
|
||
T cells. Cells were incubated with vehicle (DMSO, 0.2%) or inhibitor at the given
|
||
concentrations for 45 min at 37°C prior to T cell receptor stimulation <a href="/books/NBK50696/figure/ml119.f5/?report=objectonly" target="object" rid-ob="figobml119f5">(more...)</a></p></div></div></div></div><div id="ml119.s31"><h3>h. Detailed synthetic pathway for making probe</h3><p>This probe is commercially available from vendor, Labotest cat. No. LT00237558</p></div><div id="ml119.s32"><h3>i. Summary of probe properties (solubility, absorbance/fluorescence, reactivity, toxicity, etc.)</h3><p>The probe compound appear soluble in the assay conditions up to 100 µM concentration. Although specifically not tested, we have not observed any adverse effect of the compound on either fluorescent or colorimetric assay.</p><p>As the probe compound CID1357397 [<b><a href="/pcsubstance/?term=ML119[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML119</a>]</b> (MLS-0090801) contains a carboxylic acid, it exhibited low solubility at pH 5.0 pH but good solubility at pH 6.2 and 7.4. It had high permeability at the lower pHs tested to low permeability at pH 7.4, as more of the carboxylate anion forms. It exhibits fairly high plasma protein binding (both human and mouse). It has low stability in both human and mouse plasma. But, it shows high stability in the presence of both human and mouse microsomes (determined by the exploratory pharmacology group). The probe compound has a LD<sub>50</sub> >50µM towards Fa2N-4 immortalized human hepatocytes.</p><div id="ml119.t5" class="table"><h3><span class="label">Table 5</span><span class="title">Summary of <i>in vitro</i> ADMET/PK Properties of HePTP Inhibitor Probe</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK50696/table/ml119.t5/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml119.t5_lrgtbl__"><table class="no_margin"><thead><tr><th id="hd_h_ml119.t5_1_1_1_1" rowspan="2" colspan="1" headers="hd_h_ml119.t5_1_1_1_1" style="text-align:center;vertical-align:top;">Probe CID<br />Probe ML#<br />BCCG MLS-#</th><th id="hd_h_ml119.t5_1_1_1_2" rowspan="2" colspan="1" headers="hd_h_ml119.t5_1_1_1_2" style="text-align:center;vertical-align:top;">Aqueous Solubility<br />(μg/mL)<sup><a class="bk_pop" href="#ml119.tfn1">a</a></sup> (@ pH)</th><th id="hd_h_ml119.t5_1_1_1_3" rowspan="2" colspan="1" headers="hd_h_ml119.t5_1_1_1_3" style="text-align:center;vertical-align:top;">PAMPA Pe<br />(×10<sup>−6</sup> cm/s)<sup><a class="bk_pop" href="#ml119.tfn2">b</a></sup> (@ pH)</th><th id="hd_h_ml119.t5_1_1_1_4" colspan="2" rowspan="1" style="text-align:center;vertical-align:top;">Plasma Protein Binding (% Bound)</th><th id="hd_h_ml119.t5_1_1_1_5" rowspan="2" colspan="1" headers="hd_h_ml119.t5_1_1_1_5" style="text-align:center;vertical-align:top;">Plasma Stability<sup><a class="bk_pop" href="#ml119.tfn3">c</a></sup><br />Human Mouse/</th><th id="hd_h_ml119.t5_1_1_1_6" rowspan="2" colspan="1" headers="hd_h_ml119.t5_1_1_1_6" style="text-align:center;vertical-align:top;">Hepatic Microsome Stability<sup><a class="bk_pop" href="#ml119.tfn4">d</a></sup><br />Human/Mouse</th><th id="hd_h_ml119.t5_1_1_1_7" rowspan="2" colspan="1" headers="hd_h_ml119.t5_1_1_1_7" style="text-align:center;vertical-align:top;">Hepatic Toxicity<sup><a class="bk_pop" href="#ml119.tfn5">e</a></sup><br />LC50 (μM)</th></tr><tr><th headers="hd_h_ml119.t5_1_1_1_4" id="hd_h_ml119.t5_1_1_2_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Human<br />1μM/10μM</th><th headers="hd_h_ml119.t5_1_1_1_4" id="hd_h_ml119.t5_1_1_2_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Mouse<br />1μM/10μM</th></tr></thead><tbody><tr><td headers="hd_h_ml119.t5_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">CID1357397</td><td headers="hd_h_ml119.t5_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">6.9 (5.0)</td><td headers="hd_h_ml119.t5_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">309 (5.0)</td><td headers="hd_h_ml119.t5_1_1_1_4 hd_h_ml119.t5_1_1_2_1" rowspan="3" colspan="1" style="text-align:center;vertical-align:middle;">79.43/97.75</td><td headers="hd_h_ml119.t5_1_1_1_4 hd_h_ml119.t5_1_1_2_2" rowspan="3" colspan="1" style="text-align:center;vertical-align:middle;">77.89/95.61</td><td headers="hd_h_ml119.t5_1_1_1_5" rowspan="3" colspan="1" style="text-align:center;vertical-align:middle;">7.50/1.41</td><td headers="hd_h_ml119.t5_1_1_1_6" rowspan="3" colspan="1" style="text-align:center;vertical-align:middle;">100/100</td><td headers="hd_h_ml119.t5_1_1_1_7" rowspan="3" colspan="1" style="text-align:center;vertical-align:middle;">>50</td></tr><tr><td headers="hd_h_ml119.t5_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;"><b><a href="/pcsubstance/?term=ML119[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML119</a></b></td><td headers="hd_h_ml119.t5_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">88.7 (6.2)</td><td headers="hd_h_ml119.t5_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">117 (6.2)</td></tr><tr><td headers="hd_h_ml119.t5_1_1_1_1" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">MLS-0090801</td><td headers="hd_h_ml119.t5_1_1_1_2" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">69.6 (7.4)</td><td headers="hd_h_ml119.t5_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">8.3 (7.4)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>a</dt><dd><div id="ml119.tfn1"><p class="no_margin">in aqueous buffer, pH’s 5.0/6.2/7.4</p></div></dd><dt>b</dt><dd><div id="ml119.tfn2"><p class="no_margin">in aqueous buffer; Donor compartment pH’s 5.0/6.2/7.4; Acceptor compartment pH 7.4</p></div></dd><dt>c</dt><dd><div id="ml119.tfn3"><p class="no_margin">% remaining at 3 hr</p></div></dd><dt>d</dt><dd><div id="ml119.tfn4"><p class="no_margin">% remaining at 1 hr</p></div></dd><dt>e</dt><dd><div id="ml119.tfn5"><p class="no_margin">towards Fa2N-4 immortalized human hepatocytes</p></div></dd></dl></div></div></div></div><div id="ml119.s33"><h3>j. Probe properties</h3><div id="ml119.t6" class="table"><h3><span class="label">Table 6</span><span class="title">Properties computed from Structure</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK50696/table/ml119.t6/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__ml119.t6_lrgtbl__"><table class="no_top_margin"><thead><tr><th id="hd_h_ml119.t6_1_1_1_1" colspan="2" rowspan="1" style="text-align:center;vertical-align:top;">CID1357397 <a href="/pcsubstance/?term=ML119[synonym]" ref="pagearea=body&targetsite=entrez&targetcat=term&targettype=pubchem">ML119</a> (MLS-0090801)</th></tr></thead><tbody><tr><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Molecular Weight</td><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">468.2801</td></tr><tr><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Molecular formula</td><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">C<sub>20</sub>H<sub>10</sub>BrN<sub>3</sub>O<sub>4</sub>S</td></tr><tr><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">XLogP3-AA</td><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">4.3</td></tr><tr><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">H-Bond Donor</td><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">1</td></tr><tr><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">H-Bond Acceptor</td><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">6</td></tr><tr><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Rotatable Bond Count</td><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">3</td></tr><tr><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Exact Mass</td><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">466.957539</td></tr><tr><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MonoIsotopic Mass</td><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">466.957539</td></tr><tr><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Topological Polar Surface Area</td><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">124</td></tr><tr><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Heavy Atom Count</td><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">29</td></tr><tr><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Formal Charge</td><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">0</td></tr><tr><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Complexity</td><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">722</td></tr><tr><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Isotope Atom Count</td><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">0</td></tr><tr><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Defined Atom StereoCenter Count</td><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">0</td></tr><tr><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Undefined Atom StereoCenter Count</td><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">0</td></tr><tr><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Defined Bond StereoCenter Count</td><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">1</td></tr><tr><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Undefined Bond StereoCenter Count</td><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">0</td></tr><tr><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Covalently-Bonded Unit Count</td><td headers="hd_h_ml119.t6_1_1_1_1" rowspan="1" colspan="1" style="text-align:right;vertical-align:top;">1</td></tr></tbody></table></div></div></div></div><div id="ml119.s34"><h2 id="_ml119_s34_">4. Appendices</h2><div id="ml119.s35"><h3>a. Comparative data on (1) probe, (2) similar compound structures (establishing SAR) and (3) prior probes</h3><p>See <a class="figpopup" href="/books/NBK50696/table/ml119.t3/?report=objectonly" target="object" rid-figpopup="figml119t3" rid-ob="figobml119t3">Table 3</a> above</p></div><div id="ml119.s36"><h3>b. Comparative data showing probe specificity for target</h3><p>See <a class="figpopup" href="/books/NBK50696/table/ml119.t3/?report=objectonly" target="object" rid-figpopup="figml119t3" rid-ob="figobml119t3">Table 3</a> above</p></div></div><div id="ml119.s37"><h2 id="_ml119_s37_">5. Bibliography</h2><dl class="temp-labeled-list"><dt>1.</dt><dd><div class="bk_ref" id="ml119.r1">Hunter T, Sefton BM. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. <span><span class="ref-journal">Proc. Natl. Acad. Sci. USA. </span>1980;<span class="ref-vol">77</span>:1311–1315.</span> [<a href="/pmc/articles/PMC348484/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC348484</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6246487" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 6246487</span></a>]</div></dd><dt>2.</dt><dd><div class="bk_ref" id="ml119.r2">Mustelin T, Abraham RT, Rudd CE, Alonso A, Merlo JJ. Protein tyrosine phosphorylation in T cell signaling. <span><span class="ref-journal">Frontiers in Bioscience. </span>2001;<span class="ref-vol">7</span>:918–969.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11897562" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11897562</span></a>]</div></dd><dt>3.</dt><dd><div class="bk_ref" id="ml119.r3">Mustelin T. <span class="ref-journal">Src family tyrosine kinases in leukocytes.</span> R.G. Landes Co ; Austin, TX: 1994. pp. 1–155.</div></dd><dt>4.</dt><dd><div class="bk_ref" id="ml119.r4">Mustelin T, Rahmouni S, Bottini N, Alonso A. Role of protein tyrosine phosphatases in T cell activation. <span><span class="ref-journal">Immunol Rev. </span>2003;<span class="ref-vol"><strong>192</strong></span>:139–147.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12614357" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12614357</span></a>]</div></dd><dt>5.</dt><dd><div class="bk_ref" id="ml119.r5">Mustelin T, Taskén K. Positive and negative regulation of T cell activation through kinases and phosphatases. <span><span class="ref-journal">Biochem J. </span>2003;<span class="ref-vol"><strong>371</strong></span>:15–27.</span> [<a href="/pmc/articles/PMC1223257/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1223257</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12485116" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12485116</span></a>]</div></dd><dt>6.</dt><dd><div class="bk_ref" id="ml119.r6">Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon JE, Mustelin T. Protein tyrosine phosphatases in the human genome. <span><span class="ref-journal">Cell. </span>2004;<span class="ref-vol">117</span>:699–711.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15186772" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 15186772</span></a>]</div></dd><dt>7.</dt><dd><div class="bk_ref" id="ml119.r7">Andersen JN, et al. A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage. <span><span class="ref-journal">FASEB J. </span>2004;<span class="ref-vol"><strong>18</strong></span>:8–13.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14718383" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 14718383</span></a>]</div></dd><dt>8.</dt><dd><div class="bk_ref" id="ml119.r8">Mustelin T, Vang T, Bottini N. Protein tyrosine phosphatases and the immune response. <span><span class="ref-journal">Nat Rev Immunol. </span>2005;<span class="ref-vol"><strong>5</strong></span>:43–57.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15630428" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 15630428</span></a>]</div></dd><dt>9.</dt><dd><div class="bk_ref" id="ml119.r9">Zanke B, Suzuki H, Kishihara K, Mizzen L, Minden M, Pawson A, Mak TW. Cloning and expression of an inducible lymphoid-specific, protein tyrosine phosphatase (HePTPase). <span><span class="ref-journal">Eur J Immunol. </span>1992;<span class="ref-vol"><strong>22</strong></span>:235–239.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1530918" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 1530918</span></a>]</div></dd><dt>10.</dt><dd><div class="bk_ref" id="ml119.r10">Adachi M, Sekiya M, Isobe M, Kumura Y, Ogita Z, Hinoda Y, Imai K, Yachi A. Molecular cloning and chromosomal mapping of a human protein-tyrosine phosphatase LC-PTP. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>1992;<span class="ref-vol"><strong>186</strong></span>:1607–1615.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1510684" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 1510684</span></a>]</div></dd><dt>11.</dt><dd><div class="bk_ref" id="ml119.r11">Gjörloff-Wingren A, Saxena M, Han S, Wang X, Alonso A, Renedo M, Oh P, Williams S, Schnitzer J, Mustelin T. Subcellular localization of intracellular protein tyrosine phosphatases in T cells. <span><span class="ref-journal">Eur J Immunol. </span>2000;<span class="ref-vol"><strong>30</strong></span>:2412–2421.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10940933" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10940933</span></a>]</div></dd><dt>12.</dt><dd><div class="bk_ref" id="ml119.r12">Saxena M, Williams S, Gilman J, Mustelin T. Negative regulation of T cell antigen receptor signaling by hematopoietic tyrosine phosphatase (HePTP). <span><span class="ref-journal">J Biol Chem. </span>1998;<span class="ref-vol">273</span>:15340–15344.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9624114" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9624114</span></a>]</div></dd><dt>13.</dt><dd><div class="bk_ref" id="ml119.r13">Saxena M, Williams S, Brockdorff J, Gilman J, Mustelin T. Inhibition of T cell signaling by MAP kinase-targeted hematopoietic tyrosine phosphatase (HePTP). <span><span class="ref-journal">J Biol Chem. </span>1999;<span class="ref-vol">274</span>:11693–11700.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10206983" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10206983</span></a>]</div></dd><dt>14.</dt><dd><div class="bk_ref" id="ml119.r14">Zuniga A, Torres J, Ubeda J, Pulido R. Interaction of mitogen–activated protein kinases with the kinase interaction motif of the tyrosine phosphatase PTP-SL provides substrate specificity and retains ERK2 in the cytoplasm. <span><span class="ref-journal">J Biol Chem. </span>1999;<span class="ref-vol">274</span>:21900–21907.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10419510" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10419510</span></a>]</div></dd><dt>15.</dt><dd><div class="bk_ref" id="ml119.r15">Pulido R, Zuniga A, Ullrich A. PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif. <span><span class="ref-journal">EMBO J. </span>1998;<span class="ref-vol"><strong>17</strong></span>:7337–7350.</span> [<a href="/pmc/articles/PMC1171079/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1171079</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9857190" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 9857190</span></a>]</div></dd><dt>16.</dt><dd><div class="bk_ref" id="ml119.r16">Saxena M, Williams S, Taskén K, Mustelin T. Crosstalk between cAMP-dependent kinase and MAP kinase through hematopoietic protein tyrosine phosphatase (HePTP). <span><span class="ref-journal">Nature Cell Biology. </span>1999;<span class="ref-vol">1</span>:305–310.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10559944" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10559944</span></a>]</div></dd><dt>17.</dt><dd><div class="bk_ref" id="ml119.r17">Oh-hora M, Ogata M, Mori Y, Adachi M, Imai K, Kosugi A, Hamaoka T. Direct suppression of TCR-mediated activation of extracellular signal-regulated kinase by leukocyte protein tyrosine phosphatase, a tyrosine-specific phosphatase. <span><span class="ref-journal">J Immunol. </span>1999;<span class="ref-vol">163</span>:1282–1288.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10415025" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10415025</span></a>]</div></dd><dt>18.</dt><dd><div class="bk_ref" id="ml119.r18">Gronda M, Arab S, Iafrate B, Suzuki H, Zanke B. Hematopoietic protein tyrosine phosphatase suppresses extracellular stimulus-regulated kinase activation. <span><span class="ref-journal">Mol Cell Biol. </span>2001;<span class="ref-vol"><strong>21</strong></span>:6851–6858.</span> [<a href="/pmc/articles/PMC99862/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC99862</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11564869" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 11564869</span></a>]</div></dd><dt>19.</dt><dd><div class="bk_ref" id="ml119.r19">Nika K, Huynh H, Williams S, Paul S, Bottini N, Taskén K, Lombroso PJ, Mustelin T. Haematopoietic protein tyrosine phosphatase (HePTP) phosphorylation by cAMP-dependent protein kinase in T cells: dynamics and subcellular location. <span><span class="ref-journal">Biochem J. </span>2004;<span class="ref-vol"><strong>378</strong></span>:335–342.</span> [<a href="/pmc/articles/PMC1223964/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC1223964</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14613483" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 14613483</span></a>]</div></dd><dt>20.</dt><dd><div class="bk_ref" id="ml119.r20">Pettiford SM, Herbst R. The protein tyrosine phosphatase HePTP regulates nuclear trasnlocation of ERK2 and can modulate megakaryocytic differentiation of K562 cells. <span><span class="ref-journal">Leukemia. </span>2003;<span class="ref-vol"><strong>17</strong></span>:366–378.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12592337" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 12592337</span></a>]</div></dd><dt>21.</dt><dd><div class="bk_ref" id="ml119.r21">Saxena M, Mustelin T. Extracellular signals and scores of phosphatases: All roads lead to MAP kinase. <span><span class="ref-journal">Semin Immunol. </span>2000;<span class="ref-vol"><strong>12</strong></span>:387–396.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10995585" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 10995585</span></a>]</div></dd><dt>22.</dt><dd><div class="bk_ref" id="ml119.r22">Zanke B, Squire J, Griesser H, Henry M, Suzuki H, Patterson B, Minden M, Mak TW. A hematopoietic protein tyrosine phosphatase (HePTP) gene that is amplified and overexpressed in myeloid malignancies maps to chromosome 1q32.1. <span><span class="ref-journal">Leukemia. </span>1994;<span class="ref-vol">8</span>:236–244.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8309248" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8309248</span></a>]</div></dd><dt>23.</dt><dd><div class="bk_ref" id="ml119.r23">Fonatsch C, Haase D, Freund M, Bartels H, Tesch H. Partial trisomy 1q. A nonrandom primary chromosomal abnormality in myelodysplastic syndromes. <span><span class="ref-journal">Cancer Genet Cytogenet. </span>1991;<span class="ref-vol">56</span>:243–253.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/1756470" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 1756470</span></a>]</div></dd><dt>24.</dt><dd><div class="bk_ref" id="ml119.r24">Mamaev N, Mamaeva SE, Pavlova V, Patterson D. Combined trisomy 1q and monosomy 17p due to translocation t(1;17) in a patient with myelodysplastic syndrome. <span><span class="ref-journal">Cancer Genet Cytogenet. </span>1988;<span class="ref-vol">35</span>:21–25.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/3180004" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 3180004</span></a>]</div></dd><dt>25.</dt><dd><div class="bk_ref" id="ml119.r25">Mitelman F, Kaneko Y, Trent JM. Report of the committee on chromosome changes in neoplasia. <span><span class="ref-journal">Cytogenet Cell Genet. </span>1990;<span class="ref-vol">55</span>:358–86.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/2073841" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 2073841</span></a>]</div></dd><dt>26.</dt><dd><div class="bk_ref" id="ml119.r26">Adachi M, Sekiya M, Ishino M, Sasaki H, Hinoda Y, Imai K, Yachi A. Induction of protein-tyrosine phosphatase LC-PTP by IL-2 in human T cells. <span><span class="ref-journal">Febs Lett. </span>1994;<span class="ref-vol"><strong>338</strong></span>:47–52.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8307155" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 8307155</span></a>]</div></dd><dt>27.</dt><dd><div class="bk_ref" id="ml119.r27">Tautz L, Bruckner S, Sareth S, Alonso A, Bogetz J, Bottini N, Pellecchia M, Mustelin T. Inhibition of <em>Yersinia</em> tyrosine phosphatase by furanyl salicylate compounds. <span><span class="ref-journal">J Biol Chem. </span>2005;<span class="ref-vol"><strong>280</strong></span>:9400–9408.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15615724" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 15615724</span></a>]</div></dd><dt>28.</dt><dd><div class="bk_ref" id="ml119.r28">Bruckner S, Rahmouni S, Tautz L, Denault J-B, Alonso A, Becattini B, Salvesen GS, Mustelin T. <em>Yersinia</em> phosphatase induces mitochondrially dependent apoptosis of T cells. <span><span class="ref-journal">J Biol Chem. </span>2005;<span class="ref-vol"><strong>280</strong></span>:10388–10394.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15632192" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 15632192</span></a>]</div></dd><dt>29.</dt><dd><div class="bk_ref" id="ml119.r29">Mustelin T, Tautz L, Page R. Structure of the hematopoietic tyrosine phosphatase (HePTP) catalytic domain: structure of a KIM phosphatase with a phosphate bound at the active site. <span><span class="ref-journal">Submitted. </span>2005</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16226275" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 16226275</span></a>]</div></dd></dl></div><div id="bk_toc_contnr"></div></div></div>
|
||
<div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div><div class="small"><span class="label">Bookshelf ID: NBK50696</span><span class="label">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/21433388" title="PubMed record of this page" ref="pagearea=meta&targetsite=entrez&targetcat=link&targettype=pubmed">21433388</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/mlprobe/">Contents</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/mlprobe/ml120/" title="Previous page in this title">< Prev</a><a class="active page_link next" href="/books/n/mlprobe/ml118/" title="Next page in this title">Next ></a></div></div></div></div>
|
||
|
||
</div>
|
||
|
||
<!-- Custom content below content -->
|
||
<div class="col4">
|
||
|
||
</div>
|
||
|
||
|
||
<!-- Book content -->
|
||
|
||
<!-- Custom contetnt below bottom nav -->
|
||
<div class="col5">
|
||
|
||
</div>
|
||
</div>
|
||
|
||
<div id="rightcolumn" class="four_col col last">
|
||
<!-- Custom content above discovery portlets -->
|
||
<div class="col6">
|
||
<div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK50696&db=books">Share</a></div>
|
||
|
||
</div>
|
||
<div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK50696/?report=reader">PubReader</a></li><li><a href="/books/NBK50696/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK50696" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK50696" style="display:none" title="Cite this Page"><div class="bk_tt">Sergienko E, Bobkova E, Vasile S, et al. Selective HePTP Inhibitors: Probe 1. 2009 Nov 1 [Updated 2010 Oct 4]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK50696/pdf/Bookshelf_NBK50696.pdf">PDF version of this page</a> (658K)</li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this Page</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#ml119.s2" ref="log$=inpage&link_id=inpage">Probe Structure & Characteristics</a></li><li><a href="#ml119.s3" ref="log$=inpage&link_id=inpage">Recommendations for the scientific use of this probe</a></li><li><a href="#ml119.s4" ref="log$=inpage&link_id=inpage">Scientific Rationale for Project</a></li><li><a href="#ml119.s10" ref="log$=inpage&link_id=inpage">Project Description</a></li><li><a href="#ml119.s22" ref="log$=inpage&link_id=inpage">Probe</a></li><li><a href="#ml119.s34" ref="log$=inpage&link_id=inpage">Appendices</a></li><li><a href="#ml119.s37" ref="log$=inpage&link_id=inpage">Bibliography</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&DbFrom=books&Cmd=Link&LinkName=books_pmc_refs&IdsFromResult=2377196" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pcassay&DbFrom=books&Cmd=Link&LinkName=books_pcassay_probe&IdsFromResult=2377196" ref="log$=recordlinks">PubChem BioAssay for Chemical Probe</a><div class="brieflinkpop offscreen_noflow">PubChem BioAssay records reporting screening data for the development of the chemical probe(s) described in this book chapter</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pcsubstance&DbFrom=books&Cmd=Link&LinkName=books_pcsubstance&IdsFromResult=2377196" ref="log$=recordlinks">PubChem Substance</a><div class="brieflinkpop offscreen_noflow">Related PubChem Substances</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&DbFrom=books&Cmd=Link&LinkName=books_pubmed_refs&IdsFromResult=2377196" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21433389" ref="ordinalpos=1&linkpos=1&log$=relatedreviews&logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Selective HePTP Inhibitors: Probe 2.</a><span class="source">[Probe Reports from the NIH Mol...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Selective HePTP Inhibitors: Probe 2.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sergienko E, Bobkova E, Colayco S, Rascon J, Chan X, Vasile S, Su Y, Dahl R, Chung TDY, Dad S, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Probe Reports from the NIH Molecular Libraries Program. 2010</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/10702794" ref="ordinalpos=1&linkpos=2&log$=relatedarticles&logdbfrom=pubmed">The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP.</a><span class="source">[Oncogene. 2000]</span><div class="brieflinkpop offscreen_noflow">The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pettiford SM, Herbst R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Oncogene. 2000 Feb 17; 19(7):858-69. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/16226275" ref="ordinalpos=1&linkpos=3&log$=relatedarticles&logdbfrom=pubmed">Structure of the hematopoietic tyrosine phosphatase (HePTP) catalytic domain: structure of a KIM phosphatase with phosphate bound at the active site.</a><span class="source">[J Mol Biol. 2005]</span><div class="brieflinkpop offscreen_noflow">Structure of the hematopoietic tyrosine phosphatase (HePTP) catalytic domain: structure of a KIM phosphatase with phosphate bound at the active site.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mustelin T, Tautz L, Page R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Mol Biol. 2005 Nov 18; 354(1):150-63. Epub 2005 Oct 3.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21503265" ref="ordinalpos=1&linkpos=4&log$=relatedarticles&logdbfrom=pubmed">Inhibition of the Hematopoietic Protein Tyrosine Phosphatase by Phenoxyacetic Acids.</a><span class="source">[ACS Med Chem Lett. 2011]</span><div class="brieflinkpop offscreen_noflow">Inhibition of the Hematopoietic Protein Tyrosine Phosphatase by Phenoxyacetic Acids.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bobkova EV, Liu WH, Colayco S, Rascon J, Vasile S, Gasior C, Critton DA, Chan X, Dahl R, Su Y, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">ACS Med Chem Lett. 2011 Feb; 2(2):113-118. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21433385" ref="ordinalpos=1&linkpos=5&log$=relatedreviews&logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Small-Molecule Inhibitors of Vaccinia-H1-Related Phosphatase VHR.</a><span class="source">[Probe Reports from the NIH Mol...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Small-Molecule Inhibitors of Vaccinia-H1-Related Phosphatase VHR.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tautz L, Mustelin T, Wu S, Vossius S, Rahmouni S, Vasile S, Sergienko E, Stonich D, Yuan H, Su Y, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Probe Reports from the NIH Molecular Libraries Program. 2010</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&cmd=link&linkname=pubmed_pubmed_reviews&uid=21433388" ref="ordinalpos=1&log$=relatedreviews_seeall&logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&cmd=link&linkname=pubmed_pubmed&uid=21433388" ref="ordinalpos=1&log$=relatedarticles_seeall&logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=67d66c1684f3725e592dd428">Selective HePTP Inhibitors: Probe 1 - Probe Reports from the NIH Molecular Libra...</a><div class="ralinkpop offscreen_noflow">Selective HePTP Inhibitors: Probe 1 - Probe Reports from the NIH Molecular Libraries Program<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=2" href="/portal/utils/pageresolver.fcgi?recordid=67d66c1584f3725e592dd1ed">Selective HePTP Inhibitors: Probe 2 - Probe Reports from the NIH Molecular Libra...</a><div class="ralinkpop offscreen_noflow">Selective HePTP Inhibitors: Probe 2 - Probe Reports from the NIH Molecular Libraries Program<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=3" href="/portal/utils/pageresolver.fcgi?recordid=67d66c14cde49f3df7dcd0ad">HTS Assay for Discovery of Novel Metallo-Beta-lactamase (MBL) Inhibitors - Probe...</a><div class="ralinkpop offscreen_noflow">HTS Assay for Discovery of Novel Metallo-Beta-lactamase (MBL) Inhibitors - Probe Reports from the NIH Molecular Libraries Program<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=4" href="/portal/utils/pageresolver.fcgi?recordid=67d66c1367c23b31e0b3a2bb">Campaign to Identify Agonists of Transient Receptor Potential Channels 3 and 2 (...</a><div class="ralinkpop offscreen_noflow">Campaign to Identify Agonists of Transient Receptor Potential Channels 3 and 2 (TRPML3 & TRPML2) - Probe Reports from the NIH Molecular Libraries Program<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=5" href="/portal/utils/pageresolver.fcgi?recordid=67d66c1184f3725e592dc8a8">Campaign to identify novel modulators of the Retinoic acid receptor-related Orph...</a><div class="ralinkpop offscreen_noflow">Campaign to identify novel modulators of the Retinoic acid receptor-related Orphan Receptors (ROR) - Probe Reports from the NIH Molecular Libraries Program<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
|
||
|
||
<!-- Custom content below discovery portlets -->
|
||
<div class="col7">
|
||
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<!-- Custom content after all -->
|
||
<div class="col8">
|
||
|
||
</div>
|
||
<div class="col9">
|
||
|
||
</div>
|
||
|
||
<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
|
||
<script type="text/javascript">
|
||
(function($){
|
||
$('.skiplink').each(function(i, item){
|
||
var href = $($(item).attr('href'));
|
||
href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
|
||
$(item).on('click', function(event){
|
||
event.preventDefault();
|
||
$.scrollTo(href, 0, {
|
||
onAfter: function(){
|
||
href.focus();
|
||
}
|
||
});
|
||
});
|
||
});
|
||
})(jQuery);
|
||
</script>
|
||
</div>
|
||
<div class="bottom">
|
||
|
||
<div id="NCBIFooter_dynamic">
|
||
<!--<component id="Breadcrumbs" label="breadcrumbs"/>
|
||
<component id="Breadcrumbs" label="helpdesk"/>-->
|
||
|
||
</div>
|
||
|
||
<div class="footer" id="footer">
|
||
<section class="icon-section">
|
||
<div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
|
||
<div class="grid-container container">
|
||
<div class="icon-section_container">
|
||
<a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
|
||
<defs>
|
||
<style>
|
||
.cls-11 {
|
||
fill: #737373;
|
||
}
|
||
</style>
|
||
</defs>
|
||
<title>Twitter</title>
|
||
<path class="cls-11" d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
|
||
</path>
|
||
</svg></a>
|
||
<a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
|
||
<title>Facebook</title>
|
||
<path class="cls-11" d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
|
||
</path>
|
||
</svg></a>
|
||
<a class="footer-icon" id="footer_linkedin" href="https://www.linkedin.com/company/ncbinlm" aria-label="LinkedIn"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
|
||
<title>LinkedIn</title>
|
||
<path class="cls-11" d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
|
||
</path>
|
||
</svg></a>
|
||
<a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
|
||
<defs>
|
||
<style>
|
||
.cls-11,
|
||
.cls-12 {
|
||
fill: #737373;
|
||
}
|
||
|
||
.cls-11 {
|
||
fill-rule: evenodd;
|
||
}
|
||
</style>
|
||
</defs>
|
||
<title>GitHub</title>
|
||
<path class="cls-11" d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
|
||
</path>
|
||
<path class="cls-12" d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
|
||
</path>
|
||
<path class="cls-12" d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
|
||
</path>
|
||
<path class="cls-12" d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
|
||
<path class="cls-12" d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
|
||
</path>
|
||
<path class="cls-12" d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
|
||
</path>
|
||
<path class="cls-12" d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
|
||
</path>
|
||
<path class="cls-12" d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
|
||
</svg></a>
|
||
<a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
|
||
<svg xmlns="http://www.w3.org/2000/svg" id="Layer_1" data-name="Layer 1" viewBox="0 0 40 40">
|
||
<defs><style>.cls-1{fill:#737373;}</style></defs>
|
||
<title>NCBI Insights Blog</title>
|
||
<path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"></path>
|
||
</svg>
|
||
</a>
|
||
</div>
|
||
</div>
|
||
</section>
|
||
|
||
<section class="container-fluid bg-primary">
|
||
<div class="container pt-5">
|
||
<div class="row mt-3">
|
||
<div class="col-lg-3 col-12">
|
||
<p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
|
||
<ul class="list-inline social_media">
|
||
<li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter" target="_blank" rel="noopener noreferrer"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" x="0px" y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
|
||
<style type="text/css">
|
||
.st20 {
|
||
fill: #FFFFFF;
|
||
}
|
||
|
||
.st30 {
|
||
fill: none;
|
||
stroke: #FFFFFF;
|
||
stroke-width: 8;
|
||
stroke-miterlimit: 10;
|
||
}
|
||
</style>
|
||
<title>Twitter</title>
|
||
<g>
|
||
<g>
|
||
<g>
|
||
<path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7 c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116 c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3 c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6 C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
|
||
</g>
|
||
</g>
|
||
<circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
|
||
</g>
|
||
</svg></a></li>
|
||
<li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine" aria-label="Facebook" rel="noopener noreferrer" target="_blank">
|
||
<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" x="0px" y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
|
||
<style type="text/css">
|
||
.st10 {
|
||
fill: #FFFFFF;
|
||
}
|
||
|
||
.st110 {
|
||
fill: none;
|
||
stroke: #FFFFFF;
|
||
stroke-width: 8;
|
||
stroke-miterlimit: 10;
|
||
}
|
||
</style>
|
||
<title>Facebook</title>
|
||
<g>
|
||
<g>
|
||
<path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9 v67.5H135v-67.5h21.7L159,99.1z"></path>
|
||
</g>
|
||
</g>
|
||
<circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
|
||
</svg>
|
||
</a></li>
|
||
<li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube" target="_blank" rel="noopener noreferrer"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" x="0px" y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
|
||
<title>Youtube</title>
|
||
<style type="text/css">
|
||
.st4 {
|
||
fill: none;
|
||
stroke: #FFFFFF;
|
||
stroke-width: 8;
|
||
stroke-miterlimit: 10;
|
||
}
|
||
|
||
.st5 {
|
||
fill: #FFFFFF;
|
||
}
|
||
</style>
|
||
<circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
|
||
<g transform="translate(0,-952.36218)">
|
||
<path class="st5" d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7 v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
|
||
</g>
|
||
</svg></a></li>
|
||
</ul>
|
||
</div>
|
||
<div class="col-lg-3 col-12">
|
||
<p class="address_footer text-white">National Library of Medicine<br />
|
||
<a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323" class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br />
|
||
Bethesda, MD 20894</a></p>
|
||
</div>
|
||
<div class="col-lg-3 col-12 centered-lg">
|
||
<p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br />
|
||
<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="text-white">FOIA</a><br />
|
||
<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
|
||
</div>
|
||
<div class="col-lg-3 col-12 centered-lg">
|
||
<p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br />
|
||
<a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br />
|
||
<a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
|
||
</div>
|
||
</div>
|
||
<div class="row">
|
||
<div class="col-lg-12 centered-lg">
|
||
<nav class="bottom-links">
|
||
<ul class="mt-3">
|
||
<li>
|
||
<a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
|
||
</li>
|
||
<li>
|
||
<a class="text-white" href="https://www.nih.gov/">NIH</a>
|
||
</li>
|
||
<li>
|
||
<a class="text-white" href="https://www.hhs.gov/">HHS</a>
|
||
</li>
|
||
<li>
|
||
<a class="text-white" href="https://www.usa.gov/">USA.gov</a>
|
||
</li>
|
||
</ul>
|
||
</nav>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</section>
|
||
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>
|
||
<script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
<!--/.page-->
|
||
</div>
|
||
<!--/.wrap-->
|
||
</div><!-- /.twelve_col -->
|
||
</div>
|
||
<!-- /.grid -->
|
||
|
||
<span class="PAFAppResources"></span>
|
||
|
||
<!-- BESelector tab -->
|
||
|
||
|
||
|
||
<noscript><img alt="statistics" src="/stat?jsdisabled=true&ncbi_db=books&ncbi_pdid=book-part&ncbi_acc=NBK50696&ncbi_domain=mlprobe&ncbi_report=record&ncbi_type=fulltext&ncbi_objectid=&ncbi_pcid=/NBK50696/&ncbi_pagename=Selective HePTP Inhibitors: Probe 1 - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf&ncbi_bookparttype=chapter&ncbi_app=bookshelf" /></noscript>
|
||
|
||
|
||
<!-- usually for JS scripts at page bottom -->
|
||
<!--<component id="PageFixtures" label="styles"></component>-->
|
||
|
||
|
||
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal105 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
||
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
||
|
||
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4209313/4212053/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
|
||
</html> |